NZ701527A - Diagnostic gene marker panel for colorectal cancer - Google Patents

Diagnostic gene marker panel for colorectal cancer

Info

Publication number
NZ701527A
NZ701527A NZ701527A NZ70152713A NZ701527A NZ 701527 A NZ701527 A NZ 701527A NZ 701527 A NZ701527 A NZ 701527A NZ 70152713 A NZ70152713 A NZ 70152713A NZ 701527 A NZ701527 A NZ 701527A
Authority
NZ
New Zealand
Prior art keywords
onset
screening
present
colorectal cancer
gene marker
Prior art date
Application number
NZ701527A
Other languages
English (en)
Inventor
Peter Molloy
Lawrence Lapointe
Susanne Pedersen
Original Assignee
Clinical Genomics Pty Ltd
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Genomics Pty Ltd, Commw Scient Ind Res Org filed Critical Clinical Genomics Pty Ltd
Publication of NZ701527A publication Critical patent/NZ701527A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ701527A 2012-05-11 2013-05-10 Diagnostic gene marker panel for colorectal cancer NZ701527A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261646174P 2012-05-11 2012-05-11
PCT/AU2013/000481 WO2013166558A1 (en) 2012-05-11 2013-05-10 Diagnostic gene marker panel for colorectal cancer

Publications (1)

Publication Number Publication Date
NZ701527A true NZ701527A (en) 2016-07-29

Family

ID=49549996

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ701527A NZ701527A (en) 2012-05-11 2013-05-10 Diagnostic gene marker panel for colorectal cancer

Country Status (14)

Country Link
US (2) US11254985B2 (https=)
EP (3) EP4001436B1 (https=)
JP (3) JP6742726B2 (https=)
CN (1) CN104411835B (https=)
AU (3) AU2013258880B2 (https=)
BR (1) BR112014028122B1 (https=)
CA (3) CA3152533C (https=)
DK (3) DK3594366T3 (https=)
ES (1) ES2749514T3 (https=)
IL (1) IL235411A0 (https=)
MX (2) MX368034B (https=)
NZ (1) NZ701527A (https=)
WO (1) WO2013166558A1 (https=)
ZA (1) ZA201408120B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ621638A (en) * 2011-08-25 2016-03-31 Clinical Genomics Pty Ltd Dna methylation in colorectal and breast cancer diagnostic methods
EP4001436B1 (en) * 2012-05-11 2024-03-13 Clinical Genomics Pty. Ltd. Diagnostic gene marker panel
CA2951141C (en) * 2014-06-04 2021-11-30 Quest Diagnostics Investments Incorporated Methylated markers for colorectal cancer
JP6810612B2 (ja) 2014-06-05 2021-01-06 クリニカル ジェノミクス ピーティーワイ リミテッド メチル化分析のための方法
WO2016201365A2 (en) * 2015-06-12 2016-12-15 Visani Giuseppe Methods for treating cancers
GB201612815D0 (en) * 2016-07-25 2016-09-07 Belgian Volition Sa Novel combination test
WO2018195217A1 (en) 2017-04-19 2018-10-25 Singlera Genomics, Inc. Compositions and methods for library construction and sequence analysis
CN109371138B (zh) * 2018-12-29 2022-10-25 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep4
AU2019200359A1 (en) * 2019-01-18 2020-09-10 Clinical Genomics Pty Ltd Screening method
JP7801235B2 (ja) * 2020-03-20 2026-01-16 シングレラ・ヘルス・テクノロジーズ(シャンハイ)・リミテッド 結腸直腸新生物をスクリーニングするための方法およびキット
KR102909106B1 (ko) * 2020-08-20 2026-01-07 에스티팜 주식회사 피롤로피리딘 유도체 및 이들의 용도
CN115927607B (zh) * 2021-08-17 2024-06-07 武汉艾米森生命科技有限公司 生物标志物在胃癌诊断中的应用
WO2025213323A1 (zh) * 2024-04-08 2025-10-16 嘉兴允英医学检验有限公司 作为膀胱癌标志物的dna甲基化位点组合及其应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JPH02289917A (ja) 1990-04-25 1990-11-29 Sony Corp 回転ヘッドドラム装置
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
JP4540754B2 (ja) 1996-06-04 2010-09-08 ユニバーシティ オブ ユタ リサーチ ファウンデーション Pcr中のハイブリダイゼーションのモニタリング
WO1998049557A1 (en) 1997-04-28 1998-11-05 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
EP2330221A1 (en) 2001-09-14 2011-06-08 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
CA2489360C (en) 2002-06-26 2013-01-29 Cold Spring Harbor Laboratory Methods and compositions for determining methylation profiles
JP3711984B2 (ja) 2003-02-14 2005-11-02 日産自動車株式会社 ハイブリッド車両の制御装置
JP4453297B2 (ja) 2003-05-27 2010-04-21 トヨタ自動車株式会社 車両用遊星歯車式多段変速機
WO2005040399A2 (en) 2003-10-21 2005-05-06 Orion Genomics Llc Methods for quantitative determination of methylation density in a dna locus
WO2005085477A1 (en) 2004-03-02 2005-09-15 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
JP5336350B2 (ja) 2006-03-28 2013-11-06 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション Dnaフラグメントの増幅
JP2010527577A (ja) 2006-05-22 2010-08-19 クリニカル ジェノミクス ピーティーワイ リミテッド 検出方法
US20090075265A1 (en) * 2007-02-02 2009-03-19 Orion Genomics Llc Gene methylation in thyroid cancer diagnosis
WO2008100913A2 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
JP5535921B2 (ja) 2007-10-04 2014-07-02 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 核酸増幅
AU2008316319A1 (en) 2007-10-23 2009-04-30 Clinical Genomics Pty. Ltd. A method of diagnosing neoplasms
AU2008316313B2 (en) 2007-10-23 2015-04-16 Clinical Genomics Pty. Ltd. A method of diagnosing neoplasms - II
ES2541178T3 (es) * 2009-02-03 2015-07-16 Mdxhealth Sa Método de detección de cáncer colorrectal
WO2010135786A1 (en) 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
WO2011057354A1 (en) 2009-11-13 2011-05-19 Commonwealth Scientific And Industrial Research Organisation Epigenetic analysis
US20130012410A1 (en) * 2010-03-29 2013-01-10 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal cancer and adenoma
EP2388336A1 (en) 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
CN105886657B (zh) * 2010-09-13 2019-11-01 临床基因组学股份有限公司 结直肠癌的外遗传标记以及使用它们的诊断方法
US10041948B2 (en) * 2010-10-12 2018-08-07 Mayo Foundation For Medical Education And Research Materials and methods for determining cancer risk
WO2012054975A1 (en) 2010-10-28 2012-05-03 Clinical Genomics Pty. Ltd. Method of microvesicle enrichment
US20140155280A1 (en) 2011-05-05 2014-06-05 Commonwealth Scientific And Industrial Research Organisation Method of diagnosing neoplasms
NZ621638A (en) 2011-08-25 2016-03-31 Clinical Genomics Pty Ltd Dna methylation in colorectal and breast cancer diagnostic methods
EP4001436B1 (en) * 2012-05-11 2024-03-13 Clinical Genomics Pty. Ltd. Diagnostic gene marker panel
DK2850212T3 (da) 2012-05-18 2020-03-23 Clinical Genomics Pty Ltd Fremgangsmåde til screening for colorektal cancer
EP2922973B1 (en) * 2012-11-26 2019-03-20 Clinical Genomics Pty Ltd A method of detecting methylation
CA2951141C (en) * 2014-06-04 2021-11-30 Quest Diagnostics Investments Incorporated Methylated markers for colorectal cancer

Also Published As

Publication number Publication date
EP4001436A1 (en) 2022-05-25
BR112014028122B1 (pt) 2022-08-23
MX2014013684A (es) 2015-06-10
US20220213559A1 (en) 2022-07-07
US20150141275A1 (en) 2015-05-21
EP3594366A1 (en) 2020-01-15
JP6975807B2 (ja) 2021-12-01
JP2020089378A (ja) 2020-06-11
AU2013258880B2 (en) 2019-02-14
CN104411835A (zh) 2015-03-11
JP2015515862A (ja) 2015-06-04
JP6742726B2 (ja) 2020-08-19
DK2847355T3 (da) 2019-10-14
EP3594366B1 (en) 2021-06-23
CA3083314C (en) 2023-01-31
MX2019010935A (es) 2019-10-24
CA3083314A1 (en) 2013-11-14
CA2872867C (en) 2020-09-15
US11254985B2 (en) 2022-02-22
CA3152533A1 (en) 2013-11-14
IL235411A0 (en) 2014-12-31
AU2019201294A1 (en) 2019-03-14
CA3152533C (en) 2023-10-17
ES2749514T3 (es) 2020-03-20
EP2847355B1 (en) 2019-07-10
EP2847355A1 (en) 2015-03-18
AU2021265861B2 (en) 2024-10-10
ZA201408120B (en) 2019-11-27
WO2013166558A1 (en) 2013-11-14
CA2872867A1 (en) 2013-11-14
MX368034B (es) 2019-09-17
HK1208058A1 (en) 2016-02-19
CN104411835B (zh) 2019-12-20
EP4001436B1 (en) 2024-03-13
DK4001436T3 (da) 2024-05-27
AU2019201294B2 (en) 2021-08-19
BR112014028122A2 (https=) 2017-08-15
DK3594366T3 (da) 2021-09-13
JP6837458B2 (ja) 2021-03-03
JP2018198600A (ja) 2018-12-20
EP2847355A4 (en) 2016-05-25
AU2013258880A1 (en) 2014-11-20
AU2021265861A1 (en) 2021-12-02
WO2013166558A8 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
NZ701527A (en) Diagnostic gene marker panel for colorectal cancer
HK1246828A1 (zh) 用於检测癌症的生物标志物组
MY194686A (en) Detection of chromosome interactions
PH12014500063A1 (en) Methods and nucleic acids for determining the prognosis of a cancer subject
PH12016502411A1 (en) Method for methylation analysis
HK1217971A1 (zh) 用於核酸分析的方法、組合物和試劑盒
EP2811869A4 (en) DECORATIVE DETECTABLE WARNING PLATE WITH IMPROVED HANDLE
WO2012012725A3 (en) Methods of detecting diseases or conditions using phagocytic cells
HK1214652A1 (zh) 用於检测胰腺癌的方法和组合物
HK1206790A1 (en) Methods and compositions for providing a preeclampsia assessment
PL3523639T3 (pl) Odczynniki wykrywające i układy elektrod do elementów diagnostycznych testów wieloanalitowych oraz sposoby ich zastosowania
MX370850B (es) Marcadores metilados para cancer colorrectal.
WO2013172779A3 (en) Method for indicating the presence or non-presence of prostate cancer
WO2011106104A3 (en) Methods and compositions for the detection and treatment of cancer involving mirnas and mirna inhibitors and targets
WO2013106747A3 (en) Methods and compositions for the treatment and diagnosis of thyroid cancer
EP2837695A4 (en) NUCLEIC ACID QUANTIFICATION METHOD, DETECTION PROBE, DETECTION CONDENSATE AND NUCLEIC ACID DETERGENT PROCEDURE
HK1223508A1 (zh) 用於調節dna甲基化的組合物和方法用於調節dna甲基化的組合物和方法
MX2014013079A (es) Metodo in vitro para el diagnostico y vigilancia del cancer.
BR112013012450A2 (pt) composições, métodos de detecção e kits
EP3798316A3 (en) Genes and gene signatures for diagnosis and treatment of melanoma
GB2522566A (en) Recording the results of visibility tests at the input geometry object granularity
WO2014008426A3 (en) Diagnosis of systemic lupus erythematosus
WO2013062261A3 (en) Newly identified colon cancer marker and diagnostic kit using the same
EP3012634A4 (en) Biomarker for rheumatoid arthritis diagnosis or activity evaluation
WO2014130923A3 (en) Methods and compositions for detecting and treating drug resistant akt mutant

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAY 2018 BY CPA GLOBAL

Effective date: 20170324

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAY 2019 BY CPA GLOBAL

Effective date: 20180329

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 MAY 2020 BY CPA GLOBAL

Effective date: 20190329

LAPS Patent lapsed